Pharmacy Report Archives - Page 2 of 136 - Becker's Hospital Review

FDA expands COVID vaccine review | Healthcare groups reject hep B guidance | ASHP warns of growing drug supply threats | Eli Lilly plans $6B API plant | 1st gene therapy approved for rare syndrome

FDA actions, drug development advances and supply chain threats shape today’s news December 10, 2025 1. FDA expands COVID vaccine death review to include adults Full story 2. FDA approves 1st gene therapy for Wiskott-Aldrich syndrome Full story 3. What's…

FDA to review RSV therapies: Report | USPS delays threaten drug access | Pfizer inks $2B GLP-1 deal | Study supports single-dose HPV vaccine | CVS unveils AI platform

RSV therapy updates, mail-order drug challenges and Pfizer’s $2B deal top today’s news December 9, 2025 1. FDA to reexamine infant RSV therapies Full story 2. Mail-order drug access threatened by USPS delivery slowdowns: Report Full story 3. DSH pressure…

Trump orders vaccine schedule review | 23 drugs in shortage, discontinued | BP drug recalled | Highmark discounts MS, cancer meds | Mirum inks $620M deal for drugmaker

Drug shortages, vaccine policy shifts and drug discounts top today’s news December 8, 2025 1. Trump orders review of international immunization schedules: 3 federal vaccine updates Full story 2. 23 drugs in shortage, discontinued Full story 3. Monitor, detect, protect:…

ISMP flags fatal OR injection risk | FDA taps 2 drug chiefs | 10 systems seeking pharmacy leaders | 5 steps to lift pharmacy to system strategy | Aetna merges Rx, procedures in prior auths

Medication safety alerts, new FDA chiefs & prior auth shifts define the day. December 4, 2025 1. Patient safety groups flag fatal injection risk Full story 2. Aetna merges prescriptions, procedures into single prior authorization Full story 3. This CMIO…

Federal law expands pharmacists' scope | CVS to pay $38M in insulin case | Mount Sinai pharmacy halves prior auth times | FDA clears ranitidine after 5-year recall | Eli Lilly cuts Zepbound price

Scope expansion, faster prior auth & major settlements lead pharmacy headlines. December 3, 2025 1. Law expands pharmacists' role in opioid treatment Full story 2. Mount Sinai's pharmacy goes 'digital-first,' halves prior auth times Full story 3. Creating innovative cardiology care…

FDA reshapes drug policy | AHA sues to halt 340B rebates | WHO issues 1st GLP-1 guideline | US exempts UK-made drugs from tariffs | 14 systems named healthiest workplaces

FDA policy moves, 340B litigation & new GLP-1 guidance shape pharmacy today. December 2, 2025 1. 5 FDA moves reshaping US drug policy Full story 2. AHA sues to block 'unlawful' 340B changes: 4 things to know Full story 3.…

FDA eyes vaccine approval process changes | 9 CPO moves | Rural pharmacy recruiting: A 'glass half full' approach | FDA fast-tracks Alzheimer's drug | Wash. hospital dismisses CEO

Vaccine approval shifts, CPO moves & rural recruiting efforts shape pharmacy today. December 1, 2025 1. FDA floats changes to vaccine approval process: 5 notes Full story 2. Novo Nordisk seeks FDA approval of higher-dose Wegovy Full story 3. Preventable…

CMS' negotiated prices for 15 drugs | Pharmacy co. declines 'leadership' certification | Epic reshapes Northwell pharmacy ops | 10 systems seeking pharmacy leaders | 15 execs on tomorrow's pharmacy workforce

CMS drug pricing, certification disputes & pharmacy workforce insights. November 26, 2025 1. CMS to cut prices on 15 costly drugs in 2027 Full story 2. The great pharmacy workforce redesign: 15 leaders on key strategies Full story 3. Creating…

All-ages gene therapy, bladder cancer drug approved | Amazon's pay for 11 health jobs | Optum Rx cuts reauthorizations for 40 drugs | Most expensive hospital therapy lines: Report

Drug approvals, benefit shifts & high-cost drugs anchor pharmacy news. November 25, 2025 1. FDA approves all-ages gene therapy for spinal condition Full story 2. Optum Rx to remove reauthorization requirements for 40 drugs Full story 3. From detection to…

Top NAPLEX pass-rate schools | Eli Lilly hits $1 trillion market cap | Bill would expand CMS drug negotiation power | 32 systems' cash on hand | US drug spend far outpaces peers: Report

Schools ranked by NAPLEX pass rates & Eli Lilly hits $1 trillion. November 24, 2025 1. Top 15 pharmacy schools by NAPLEX pass rates Full story 2. Eli Lilly 1st pharma company to reach $1 trillion market cap Full story…